Terms: = Ovarian cancer AND WT1, WAGR, 7490, ENSG00000184937, WT33, GUD, WIT-2 AND Staging
4 results:
1. ovarian Mesonephric-Like Adenocarcinoma With Recurrent Liver Metastases: A Case Report with Analysis of Therapeutic Molecular Targets.
Sugitani A; Ogawa A; Yoshida H; Kobayashi-Kato M; Kikkawa N; Tanase Y; Uno M; Ishikawa M; Kato T
Int J Surg Pathol; 2024 May; 32(3):578-585. PubMed ID: 37345348
[TBL] [Abstract] [Full Text] [Related]
2. [Expression of ARID1A in ovarian seromucinous neoplasms and its clinicopathological significance].
Ding XH; Tian X; Wang LQ; Wang Y; Liu AJ
Zhonghua Bing Li Xue Za Zhi; 2020 Jun; 49(6):588-593. PubMed ID: 32486536
[No Abstract] [Full Text] [Related]
3. Detection of Abundant Non-Haematopoietic Circulating cancer-Related Cells in Patients with Advanced Epithelial ovarian cancer.
Kumar J; Chudasama D; Roberts C; Kubista M; Sjöback R; Chatterjee J; Anikin V; Karteris E; Hall M
Cells; 2019 Jul; 8(7):. PubMed ID: 31319587
[No Abstract] [Full Text] [Related]
4. An immunohistochemical panel to distinguish ovarian from uterine serous papillary carcinomas.
Zhang Y; Garcia-Buitrago MT; Koru-Sengul T; Schuman S; Ganjei-Azar P
Int J Gynecol Pathol; 2013 Sep; 32(5):476-81. PubMed ID: 23896709
[TBL] [Abstract] [Full Text] [Related]
